POLR2A mutation was a poor prognostic marker associated with the recurrence of cerebellopontine angle (CPA) meningioma[47]; our study verified that high expression of POLR2A protein predicts a short survival time in HNSCC patients. The gene discussed is POLR2A; the disease is head and neck squamous cell carcinoma.